Cost of starting colorectal cancer screening programs: Results from five federally funded demonstration programs

Preventing Chronic Disease

Volumn 5, Issue 2, 2008, Pages

  Tangka, Florence K L ^a   Subramanian, Sujha ^c   Bapat, Bela ^c   Seeff, Laura C ^b   DeGroff, Amy ^b   Gardner, James ^b   Blythe Ryerson, A ^b   Nadel, Marion ^b   Royalty, Janet ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORECTAL TUMOR; COMMUNITY CARE; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HUMAN; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH SERVICE; TIME; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COLORECTAL NEOPLASMS; COMMUNITY HEALTH SERVICES; FINANCING, GOVERNMENT; HUMANS; MASS SCREENING; MEDICALLY UNDERSERVED AREA; TIME FACTORS; UNITED STATES;

EID: 84978413962     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000;95(4):868-77.
2. Subramanian S, Amonkar MM, Hunt TL. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2005;14(2):409-16.
3. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100(10):2093-103.
4. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(2):96-104.
5. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2007;50(1);34-49.
6. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(2):132-41.
7. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001;111(8):593-601.
8. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284(15):1954-61.
9. DeGroff A, Holden D, Green SG, Boehm J, Seeff LC, Tangka F. Starting up the Colorectal Cancer Screening Demonstration Project. Prev Chronic Dis 2008;5(2). http://www.cdc.gov/pcd/issues/2008/apr/07_0204.htm.
10. Seeff LC, DeGroff A, Tangka F, Wanliss E, Major A, Nadel M, et al. Development of a federally funded demonstration program to screen for colorectal cancer. Prev Chronic Dis 2008;5(2). http://www.cdc.gov/pcd/issues/2008/apr/07_0206.htm.
11. French MT, Dennis ML, McDougal GL, Karuntzos GT, Hubbard RL. Training and employment programs in methadone treatment: client needs and desires. J Subst Abuse Treat 1992;9(4):293-303.
12. French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat 1997;14(5):445-55.
13. French MT, Roebuck MC, McLellan AT. Cost estimation when time and resources are limited: the brief DATCAP. J Subst Abuse Treat 2004;27(3):187-93.
14. Salome HJ, French MT, Miller M, McLellan AT. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug Alcohol Depend 2003;71(2):195-206.